GlassScriptPhysician profile
Bart Allen Macdonald
NPI 1295894731
$1,894.21
in general payments reported to CMS, 2019-2025
14 companies · $79.22 in 2025
The $79.22 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $69.59 · 2021: $44.21 · 2023: $313 · 2024: $239 · 2025: $79.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,273.59 | 2019-2025 | Mars 3v/3vl, Senza |
| Providence Medical Technology, INC. | $210.86 | 2023 | |
| Spineology INC. | $86.93 | 2020-2025 | |
| Depuy Synthes Sales INC. | $59.86 | 2019-2024 | Expedium Verse |
| Medtronic, INC. | $54.83 | 2023-2025 | Strata, Unid_pass |
| Lemaitre Vascular, INC. | $31.47 | 2023 | Anastoclip Gc 8cm (Medium) |
| Astrazeneca Pharmaceuticals LP | $26.12 | 2024 | Andexxa |
| Spine Wave, INC. | $25.20 | 2023 | Spinal Implant |
| Portola Pharmaceuticals, LLC | $24.35 | 2020 | |
| Bioventus LLC | $24.19 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Baxter Healthcare | $24.02 | 2023 | Floseal |
| Abbvie INC. | $21.39 | 2024 | |
| Heron Therapeutics, INC. | $20.02 | 2024 | Zynrelef |
| Medtronic USA, INC. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.